Inventor · disambiguated record
Yosup Rew
Also filed as: REW YOSUP
28 granted patents·16 pending applications·90 citations·filing 2005–2025
95Inventor score
Top patents by PatentIndex Score
44 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0593US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0690US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 0790US8952036B2Benzoic acid derivative MDM2 inhibitor for the treatment of cancerAMGEN INC·Filed 2014·Granted Feb 10, 2015·15 cites·39 claims
- 0888US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0988US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1087US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1186US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1285US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1383US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1481US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1579US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 1679US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 1778US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 1876US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 1976US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2076US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2171US7659287B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2007·Granted Feb 9, 2010·1 cites·8 claims
- 2270US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2370US2025121087A1Antibody-drug conjugates comprising anti-b7-h3 antibodiesINTOCELL INC·Filed 2024·Application pending·0 cites
- 2469US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2567US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2665US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2764US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2864US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2963US2025213712A1Antibody drug conjugates comprising camptothecin derivatives and uses thereofINTOCELL INC·Filed 2024·Application pending·0 cites
- 3062US2024140966A1Amorphous and crystalline forms of mcl-1 antagonistsAMGEN INC·Filed 2023·Application pending·0 cites
- 3161US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3259US12168060B2Antibody-drug conjugates comprising anti-B7-H3 antibodiesINTOCELL INC·Filed 2021·Granted Dec 17, 2024·0 cites·22 claims
- 3359US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 3459US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 3558US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 3656US2023190939A1Antibody drug conjugates comprising toxins with polar groups and uses thereofINTOCELL INC·Filed 2022·Application pending·0 cites
- 3746US2021122730A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3846US2016002185A1Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Application pending·0 cites
- 3944US11274105B2Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonistsAMGEN INC·Filed 2019·Granted Mar 15, 2022·0 cites·15 claims
- 4044US8772296B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2007·Granted Jul 8, 2014·0 cites·23 claims
- 4144US2022079924A1Glucocorticoid receptor modulatorsORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4243US11407721B2CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2018·Granted Aug 9, 2022·0 cites·46 claims
- 4343US8076376B2Aniline sulfonamide derivatives and their usesPOWERS JAY P·Filed 2006·Granted Dec 13, 2011·0 cites·23 claims
- 4442US11208432B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Dec 28, 2021·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Yosup Rew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →